Beyond Therapies

We have breadth and depth in clinical, scientific and commercial understanding. We conduct research for clinically complex and specialist indication areas, alongside general, primary care indications. Our top therapy areas to work in are:

Oncology

Neurology

Cardiology

Immunology

Oncology

Neurology

Cardiology

Immunology

For decades, clients have returned to us with their business challenges in the oncology space.

 

Oncology is an evolving therapy area, with advances in disease understanding, new technology mechanisms, new targets and greater fragmentation of patient cohorts – all of which contribute to the complexity of treatment.

We understand that pharma companies require a strategic research team who not only keeps abreast of the changes in the marketplace, conference activity and latest thinking, but who also has…

  • A deep appreciation of the science
  • An understanding of the market dynamics
  • A technical understanding of the stakeholders involved
  • Appropriate recruitment strategies
  • Senior-level interpretation to deliver meaningful and actionable insights

We have a solid reputation working in this complex and fast-moving space. With around 30% of our business being in oncology, we have an internal team of senior experts who work on oncology engagements and take insights further to ensure we continue to exceed our clients’ expectations.

If you would like to find out more about how we can support your pre-launch or post-launch oncology needs or how you could become a strategic partner, get in touch with our Research Directors: Lindsay, Siobhan or Paula. We support through the scoping out of initial needs to research design, analysis and beyond.

We have extensive expertise in neurology, across many different indications such as Multiple Sclerosis, Parkinson’s Disease, Neuromyelitis Optica Spectrum Disorder, Myasthenia Gravis and Huntington’s Disease.

Our knowledge and experience ensures we deliver extra layers of confidence and insight to our high-quality research.

Recent projects have included:

  • Patient journey and TPP assessment in Myasthenia Gravis
  • Clinical trial scenario testing in Parkinson’s Disease
  • Lexicon research in Huntington’s Disease
  • Patient chart audit in NMOSD

See our latest thinking for more insights!

For decades, clients have returned to us with their business challenges in the oncology space.

 

Oncology is an evolving therapy area, with advances in disease understanding, new technology mechanisms, new targets and greater fragmentation of patient cohorts – all of which contribute to the complexity of treatment.

We understand that pharma companies require a strategic research team who not only keeps abreast of the changes in the marketplace, conference activity and latest thinking, but who also has…

  • A deep appreciation of the science
  • An understanding of the market dynamics
  • A technical understanding of the stakeholders involved
  • Appropriate recruitment strategies
  • Senior-level interpretation to deliver meaningful and actionable insights

We have a solid reputation working in this complex and fast-moving space. With around 30% of our business being in oncology, we have an internal team of senior experts who work on oncology engagements and take insights further to ensure we continue to exceed our clients’ expectations.

If you would like to find out more about how we can support your pre-launch or post-launch oncology needs or how you could become a strategic partner, get in touch with our Research Directors: Lindsay, Siobhan or Paula. We support through the scoping out of initial needs to research design, analysis and beyond.

We have extensive expertise in neurology, across many different indications such as Multiple Sclerosis, Parkinson’s Disease, Neuromyelitis Optica Spectrum Disorder, Myasthenia Gravis and Huntington’s Disease.

Our knowledge and experience ensures we deliver extra layers of confidence and insight to our high-quality research.

Recent projects have included:

  • Patient journey and TPP assessment in Myasthenia Gravis
  • Clinical trial scenario testing in Parkinson’s Disease
  • Lexicon research in Huntington’s Disease
  • Patient chart audit in NMOSD

See our latest thinking for more insights!